Valeo Financial Advisors’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Buy
+6,033
New +$247K 0.01% 589
2025
Q2
Sell
-13,003
Closed -$513K 818
2025
Q1
$513K Sell
13,003
-529
-4% -$17.8K 0.01% 410
2024
Q4
$407K Buy
13,532
+3,309
+32% +$95K 0.01% 458
2024
Q3
$239K Buy
+10,223
New +$223K 0.01% 600
2024
Q2
Sell
-43,344
Closed -$606K 719
2024
Q1
$606K Sell
43,344
-19,956
-32% -$318K 0.02% 320
2023
Q4
$1.08M Buy
63,300
+1,500
+2% +$17.4K 0.04% 213
2023
Q3
$517K Buy
61,800
+1,500
+2% +$20.9K 0.02% 323
2023
Q2
$1.5M Sell
60,300
-5,000
-8% -$129K 0.07% 153
2023
Q1
$982K Sell
65,300
-3,500
-5% -$53.2K 0.05% 216
2022
Q4
$814K Buy
68,800
+35,900
+109% +$261K 0.04% 212
2022
Q3
$195K Sell
32,900
-9,100
-22% -$59.7K 0.01% 446
2022
Q2
$178K Buy
42,000
+24,900
+146% +$155K 0.01% 442
2022
Q1
$163K Sell
17,100
-5,500
-24% -$63.7K 0.01% 559
2021
Q4
$429K Buy
22,600
+6,400
+40% +$166K 0.02% 343
2021
Q3
$539K Buy
+16,200
New +$501K 0.03% 280
2021
Q2
Sell
-1,000
Closed -$48K 1701
2021
Q1
$48K Buy
1,000
+500
+100% +$24K ﹤0.01% 891
2020
Q4
$26K Hold
500
﹤0.01% 965
2020
Q3
$13K Buy
+500
New +$11.5K ﹤0.01% 1027

Other funds holding TGTX